Kindred Biosciences (KIN) Tops Q4 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Kindred Biosciences (KIN) Tops Q4 EPS by 12c

Kindred Biosciences Announces Fourth Quarter and Year-End 2015 Financial Results

March 2, 2016 4:01 PM EST

SAN FRANCISCO, March 2, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the fourth quarter and full year ended December 31, 2015.  

"We are very pleased with the progress on Zimeta, our lead product candidate, and look forward to our first product approval and launch," stated Richard Chin, M.D., President and CEO of KindredBio. "We are also pleased to report that the strong pipeline of additional products, including KIND-010 for management of weight in... More